Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Accelerated Radiotherapy-Chemotherapy vs Very Accelerated Radiotherapy in Advanced Head and Neck Cancer
NCT00162708Phase 3Completed
- Sponsor
- Gustave Roussy
- Start
- Jul 1996
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Cisplatin micelle injection (HA132) and fluorouracil in head and neck squamous cell carcinoma (HNSCC) (2 arms), sponsored by Gustave Roussy. Primary endpoint: Event-Free Survival. Started Jul 1996; status: completed.
02
Drugs
Cisplatin micelle injection (HA132)fluorouracil
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT00162708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00162708.